83 FR 58778 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 225 (November 21, 2018)

Page Range		58778-58779
FR Document		2018-25355

Federal Register, Volume 83 Issue 225 (Wednesday, November 21, 2018)

[Federal Register Volume 83, Number 225 (Wednesday, November 21, 2018)]
[Notices]
[Pages 58778-58779]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-25355]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Review of R35 Research Program 
Award.
    Date: December 3-4, 2018.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites Alexandria Old Town, Virginia Ballroom A & 
B, 1900 Diagonal Rd, Alexandria, VA 22314.
    Contact Person: Jimok Kim, Ph.D., Scientific Review Officer, 
Scientific Review Branch, Division of Extramural Activities, NINDS/
NIH/DHHS, NSC, 6001 Executive Blvd., Suite 3226, MSC 9529, Bethesda, 
MD 20892-9529, (301) 496-9223, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Biomarkers Discovery in 
Parkinsonism.
    Date: December 3, 2018.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Joel A. Saydoff, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Blvd., Suite 3205, 
MSC 9529, Bethesda, MD 20892-9529, (301) 496-9223, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research

[[Page 58779]]

Related to Neurological Disorders; 93.854, Biological Basis Research 
in the Neurosciences, National Institutes of Health, HHS)

    Dated: November 14, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-25355 Filed 11-20-18; 8:45 am]
BILLING CODE 4140-01-P

58778 Federal Register / Vol. 83, No. 225 / Wednesday, November 21, 2018 / Notices

A copy of the ACBTSA charter is Dated: November 15, 2018. DEPARTMENT OF HEALTH AND
available on the Committee’s website at Ronald J. Livingston, Jr., HUMAN SERVICES
https://www.hhs.gov/ohaidp/initiatives/ Program Analyst, Office of Federal Advisory
blood-tissue-safety/advisory-committee/ Committee Policy. National Institutes of Health
charter/index.html. A copy of the [FR Doc. 2018–25354 Filed 11–20–18; 8:45 am]
charter can also be obtained by National Institute of Neurological
accessing the FACA database that is
BILLING CODE 4140–01–P Disorders and Stroke; Notice of Closed
maintained by the Committee Meetings
Management Secretariat under the DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the
General Services Administration. The HUMAN SERVICES Federal Advisory Committee Act, as
website address for the FACA database amended, notice is hereby given of the
is www.facadatabase.gov. National Institutes of Health following meetings.
Dated: October 19, 2018. The meetings will be closed to the
James J. Berger, National Institute on Aging; Notice of public in accordance with the
Senior Advisor for Blood and Tissue Policy, Closed Meeting provisions set forth in sections
Designated Federal Officer, Advisory 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Committee on Blood and Tissue Safety and Pursuant to section 10(d) of the as amended. The grant applications and
Availability. Federal Advisory Committee Act, as the discussions could disclose
[FR Doc. 2018–25374 Filed 11–20–18; 8:45 am] amended, notice is hereby given of the confidential trade secrets or commercial
BILLING CODE 4150–41–P following meeting. property such as patentable material,
and personal information concerning
The meeting will be closed to the
individuals associated with the grant
public in accordance with the
DEPARTMENT OF HEALTH AND applications, the disclosure of which
provisions set forth in sections would constitute a clearly unwarranted
HUMAN SERVICES
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy.
National Institutes of Health as amended. The grant applications and
the discussions could disclose Name of Committee: National Institute of
Neurological Disorders and Stroke Special
National Heart, Lung, and Blood confidential trade secrets or commercial Emphasis Panel; Review of R35 Research
Institute; Notice of Closed Meeting property such as patentable material, Program Award.
Pursuant to section 10(d) of the and personal information concerning Date: December 3–4, 2018.
individuals associated with the grant Time: 8:00 a.m. to 6:00 p.m.
Federal Advisory Committee Act, as
applications, the disclosure of which Agenda: To review and evaluate grant
amended, notice is hereby given of the applications.
following meeting. would constitute a clearly unwarranted
Place: Embassy Suites Alexandria Old
The meeting will be closed to the invasion of personal privacy. Town, Virginia Ballroom A & B, 1900
public in accordance with the Name of Committee: National Institute on Diagonal Rd, Alexandria, VA 22314.
provisions set forth in sections Aging Special Emphasis Panel; Health and Contact Person: Jimok Kim, Ph.D.,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Aging Trends. Scientific Review Officer, Scientific Review
as amended. The grant applications and Branch, Division of Extramural Activities,
Date: December 3, 2018.
the discussions could disclose NINDS/NIH/DHHS, NSC, 6001 Executive
Time: 2:00 p.m. to 5:00 p.m. Blvd., Suite 3226, MSC 9529, Bethesda, MD
confidential trade secrets or commercial Agenda: To review and evaluate grant 20892–9529, (301) 496–9223, Jimok.kim@
property such as patentable material, applications. nih.gov.
and personal information concerning Place: National Institute on Aging, This notice is being published less than 15
individuals associated with the grant Gateway Building, Room 2W200, 7201 days prior to the meeting due to the timing
applications, the disclosure of which Wisconsin Avenue, Bethesda, MD 20892, limitations imposed by the review and
would constitute a clearly unwarranted (Telephone Conference Call). funding cycle.
invasion of personal privacy. Contact Person: Kimberly Firth, Ph.D., Name of Committee: National Institute of
Name of Committee: Heart, Lung, and National Institutes of Health, National Neurological Disorders and Stroke Special
Blood Initial Review Group; NHLBI Institute on Aging, Gateway Building, 7201 Emphasis Panel; Biomarkers Discovery in
Institutional Training Mechanism Review Wisconsin Avenue, Suite 2C212, Bethesda, Parkinsonism.
Committee. MD 20892, 301–402–7702, firthkm@ Date: December 3, 2018.
Date: December 14, 2018. mail.nih.gov. Time: 9:00 a.m. to 5:00 p.m.
Time: 9:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant
Agenda: To review and evaluate grant This notice is being published less than 15 applications.
applications. days prior to the meeting due to the timing Place: National Institutes of Health,
Place: National Institutes of Health, 6701 limitations imposed by the review and Neuroscience Center, 6001 Executive
Rockledge Drive, Bethesda, MD 20892 funding cycle. Boulevard, Rockville, MD 20852, (Telephone
(Telephone Conference Call). Conference Call).
(Catalogue of Federal Domestic Assistance
Contact Person: Lindsay M. Garvin, Ph.D., Contact Person: Joel A. Saydoff, Ph.D.,
Program Nos. 93.866, Aging Research, Scientific Review Officer, Scientific Review
Scientific Review Officer, Office of Scientific
National Institutes of Health, HHS) Branch, Division of Extramural Activities,
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive; Suite Dated: November 15, 2018. NINDS/NIH/DHHS, NSC, 6001 Executive
7189, Bethesda, MD 20892, 301–827–7911, Blvd., Suite 3205, MSC 9529, Bethesda, MD
Natasha M. Copeland,
khammond on DSK30JT082PROD with NOTICES

lindsay.garvin@nih.gov. 20892–9529, (301) 496–9223, Joel.saydoff@
Program Analyst, Office of Federal Advisory nih.gov.
(Catalogue of Federal Domestic Assistance
Committee Policy. This notice is being published less than 15
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and [FR Doc. 2018–25351 Filed 11–20–18; 8:45 am] days prior to the meeting due to the timing
Vascular Diseases Research; 93.838, Lung BILLING CODE 4140–01–P limitations imposed by the review and
Diseases Research; 93.839, Blood Diseases funding cycle.
and Resources Research, National Institutes (Catalogue of Federal Domestic Assistance
of Health, HHS) Program Nos. 93.853, Clinical Research

VerDate Sep<11>2014 16:08 Nov 20, 2018 Jkt 247001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 E:\FR\FM\21NON1.SGM 21NON1

Federal Register / Vol. 83, No. 225 / Wednesday, November 21, 2018 / Notices 58779

Related to Neurological Disorders; 93.854, DEPARTMENT OF HEALTH AND SUMMARY: This notice is to inform the
Biological Basis Research in the HUMAN SERVICES public that the Substance Abuse and
Neurosciences, National Institutes of Health, Mental Health Services Administration
HHS) National Institutes of Health (SAMHSA) intends to award $500,000
Dated: November 14, 2018. (total costs) for up to five years to
Center for Scientific Review; Notice of CADCA for the National Anti-Drug
Sylvia L. Neal,
Closed Meeting Coalitions Training and Workforce
Program Analyst, Office of Federal Advisory
Committee Policy. Pursuant to section 10(d) of the Development Grant. Under this
Federal Advisory Committee Act, as initiative, CADCA will provide training
[FR Doc. 2018–25355 Filed 11–20–18; 8:45 am]
amended, notice is hereby given of the to state and community prevention
BILLING CODE 4140–01–P
following meeting. leaders, including members of anti-drug
The meeting will be closed to the community coalitions from around the
public in accordance with the country who are committed to
DEPARTMENT OF HEALTH AND
provisions set forth in sections addressing the evolving needs of the
HUMAN SERVICES behavioral health field, and promote
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
National Institutes of Health as amended. The grant applications and workforce development. Training and
the discussions could disclose workforce development activities
National Heart, Lung, and Blood confidential trade secrets or commercial supported through this grant include
Institute; Notice of Meetings property such as patentable material, SAMHSA’s Prevention Day, the CADCA
and personal information concerning National Leadership Forum, and
Pursuant to section 10(d) of the individuals associated with the grant CADCA’s Mid-Year Training Institute.
Federal Advisory Committee Act, as applications, the disclosure of which These activities aim to disseminate
amended, notice is hereby given of the would constitute a clearly unwarranted knowledge and transfer state-of-the-art
following meetings. invasion of personal privacy. information, assisting state and
community leaders in developing and
The meetings will be closed to the Name of Committee: Center for Scientific implementing evidence-based programs,
public in accordance with the Review Special Emphasis Panel; Member
Conflict: Chronic Neurodegenerative practices, and policies aligned with the
provisions set forth in sections 21st Century Cures Act, the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Diseases.
Date: December 11, 2018. Comprehensive Addition and Recovery
as amended. The grant applications and Time: 1:00 p.m. to 3:30 p.m. Act, the President’s Commission on
the discussions could disclose Agenda: To review and evaluate grant combating drug addiction and the
confidential trade secrets or commercial applications. opioid crisis, and other national
property such as patentable material, Place: National Institutes of Health, 6701 substance abuse prevention goals,
and personal information concerning Rockledge Drive, Bethesda, MD 20892 outcomes, and efforts, including
individuals associated with the grant (Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D.,
underage drinking prevention. This is
applications, the disclosure of which not a formal request for applications.
would constitute a clearly unwarranted Scientific Review Officer, Center for
Scientific Review, National Institutes of Assistance will be provided only to
invasion of personal privacy. Health, 6701 Rockledge Drive, Room 5194, CADCA based on the receipt of a
Name of Committee: National Heart, Lung, MSC 7846, Bethesda, MD 20892, (301) 237– satisfactory application that is approved
and Blood Institute Special Emphasis Panel; 9838, bhagavas@csr.nih.gov. by an independent review group.
Conference Grants in Support of Heart, Lung, (Catalogue of Federal Domestic Assistance Funding Opportunity Title: SP–19–
and Blood Research. Program Nos. 93.306, Comparative Medicine; 002.
Date: December 11–12, 2018. 93.333, Clinical Research, 93.306, 93.333, Catalog of Federal Domestic
Time: 8:00 a.m. to 5:30 p.m. 93.337, 93.393–93.396, 93.837–93.844, Assistance (CFDA) Number: 93.243.
Agenda: To review and evaluate grant 93.846–93.878, 93.892, 93.893, National Authority: Section 516 of the Public
applications. Institutes of Health, HHS) Health Services Act, as amended.
Place: National Institutes of Health, 6701 Dated: November 15, 2018.
Rockledge Drive, Room 7296, Bethesda, MD Justification
Ronald J. Livingston, Jr.,
20892 (Virtual Meeting). Eligibility for this award is limited to
Program Analyst, Office of Federal Advisory
Contact Person: Stephanie J. Webb, Ph.D., CADCA. The purpose of this grant to
Committee Policy.
Scientific Review Officer, Office of Scientific provide training and workforce
[FR Doc. 2018–25356 Filed 11–20–18; 8:45 am]
Review, National Heart, Lung, and Blood development for thousands of members
Institute, National Institutes of Health, 6701 BILLING CODE 4140–01–P
of community coalitions dedicated to
Rockledge Drive, Room 7196, Bethesda, MD
preventing substance abuse through a
20892, 301–287–7332, stephanie.webb@
DEPARTMENT OF HEALTH AND national leadership workforce
nih.gov.
HUMAN SERVICES development and training event.
(Catalogue of Federal Domestic Assistance CADCA is the only national
Program Nos. 93.233, National Center for
Substance Abuse and Mental Health organization that has special expertise
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Services Administration and unique broad, national-level
Diseases Research; 93.839, Blood Diseases experience in working with community
Fiscal Year (FY) 2019 Funding anti-drug coalitions. For more than 22
and Resources Research, National Institutes
Opportunity years, coalitions and coalition
khammond on DSK30JT082PROD with NOTICES

of Health, HHS)
AGENCY: Substance Abuse and Mental leadership have turned to CADCA to
Dated: November 15, 2018.
Health Services Administration, HHS. obtain the assistance they need to
Ronald J. Livingston, Jr., implement, operate, and sustain
ACTION: Notice of intent to award a
Program Analyst, Office of Federal Advisory effective local community anti-drug
Committee Policy. single source grant to the Community
strategies. CADCA will take advantage
Anti-Drug Coalitions of America
[FR Doc. 2018–25353 Filed 11–20–18; 8:45 am] of the resources of multiple agencies
(CADCA).
BILLING CODE 4140–01–P located throughout the federal, state and

VerDate Sep<11>2014 16:08 Nov 20, 2018 Jkt 247001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 E:\FR\FM\21NON1.SGM 21NON1

Document Created: 2018-11-21 03:11:14
Document Modified: 2018-11-21 03:11:14

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		December 3-4, 2018.
FR Citation		83 FR 58778

83 FR 58778 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 225 (November 21, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health